It's one of many steps for the company as it builds the infrastructure for what "will change medicine everywhere in the world ...

Quanterix Corp. agreed to acquire life sciences peer Akoya Biosciences Inc. in an all-stock deal, combining two companies ...

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in ...

This Genomic Biomarkers market report covers market characteristics, size and growth, segmentation, regional and country ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...

Zentalis Pharmaceuticals has won a U.S. Food and Drug Administration fast-track designation for its lead product candidate azenosertib for certain cancer patients with high levels of the Cyclin E1 ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative ...

AMSBIO’s EZ-Spread™ Plating Beads offer a faster, safer, and more efficient way to plate bacterial and yeast cells on agar ...

Learn how this client partnered with Azenta Life Sciences to integrate industry-leading sample capabilities and ...

Evercore ISI raised the firm’s price target on Azenta (AZTA) to $50 from $48 and keeps an In Line rating on the shares. In the firm’s 2025 ...

research and laboratory facilities." The School has been awarded the prestigious Athena SWAN Gold award in recognition of its work to support women in science.